Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alzamend Neuro ( (ALZN) ) has issued an announcement.
Between July 23, 2025, and July 30, 2025, Alzamend Neuro, Inc. issued 243,429 shares of common stock following the conversion of 564.76 shares of Series B Convertible Preferred Stock. This issuance increased the total outstanding shares of common stock to 3,139,861 as of July 30, 2025, reflecting a strategic financial maneuver to optimize the company’s capital structure.
The most recent analyst rating on (ALZN) stock is a Buy with a $50.00 price target. To see the full list of analyst forecasts on Alzamend Neuro stock, see the ALZN Stock Forecast page.
More about Alzamend Neuro
Average Trading Volume: 1,689,718
Technical Sentiment Signal: Sell
Current Market Cap: $6.52M
For an in-depth examination of ALZN stock, go to TipRanks’ Overview page.